Expanded access.
D000225:Adenine / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006297:Health Services Accessibility; D006801:Humans; D061466:Lopinavir; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D061466:Lopinavir; D000068698:Tenofovir; D000225:Adenine